Open AccessCOVID-19 Outcomes Among Solid Organ Transplant Recipients: A Case-control Study
Author(s) -
Pratima Sharma,
Vincent Chen,
Christopher Fung,
Jonathan P. Troost,
Vaiibhav Patel,
M.P. Combs,
Silas P. Norman,
Puneet Garg,
Monica Colvin,
Keith D. Aaronson,
Christopher J. Sonnenday,
Jonathan L. Golob,
Emily C. Somers,
Mona M. Doshi
Publication year - 2020
Publication title -
transplantation
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000003447
Subject(s) - medicine , hydroxychloroquine , hazard ratio , odds ratio , immunosuppression , kidney transplantation , renal replacement therapy , covid-19 , transplantation , disease , confidence interval , infectious disease (medical specialty)
Solid organ transplant (SOT) recipients are considered to be "vulnerable" to COVID-19 infection due to immunosuppression. To date, there are no studies that compared the disease severity of COVID-19 in SOT recipients with nontransplant patients.